2026 Autoimmune Neurology Conference | C19 - Focus on Emerging Diagnostics
| 02:45 PM - 03:12 PM CDT | Speaker |
Antibody Discovery Approaches from Bench to Bedside
Divyanshu Dubey, MD, FAAN |
| 03:12 PM - 03:39 PM CDT | Speaker |
Neural Antibody Testing Pitfalls
Tammy L. Smith, MD, PhD |
| 03:39 PM - 04:06 PM CDT | Speaker |
Neural Injury Biomarkers in Autoimmune Neurology
Sara Mariotto, MD, PhD |
| 04:06 PM - 04:16 PM CDT | Speaker |
Abstract Presentation #1
|
| 04:16 PM - 04:26 PM CDT | Speaker |
Abstract Presentation #2
|
| Friederike A. Arlt, MD | Dr. Arlt has received research support from Kompetenznetzwerk Peripherer Nerv (KKPNS). |
| Tammy L. Smith, MD, PhD | Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca. |
| Surendra Dasari | Surendra Dasari has nothing to disclose. |
| Reghann LaFrance-Corey | Miss LaFrance-Corey has nothing to disclose. |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Adrian Budhram, MD | Dr. Budhram has nothing to disclose. |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Connie Lesnick | Connie Lesnick has nothing to disclose. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Ramona Miske | Ramona Miske has received personal compensation for serving as an employee of Euroimmun. Ramona Miske has received intellectual property interests from a discovery or technology relating to health care. |
| Elizabeth A. Hartman, MD, FAAN | An immediate family member of Dr. Hartman has or had stock in Amgen. |
| Rana K. Zabad, MD, FAAN | Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals. |
| Yong Guo | Yong Guo has nothing to disclose. |
| Sara Mariotto, MD, PhD | Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, AAN. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck. The institution of Dr. Mariotto has received research support from Euroimmun. The institution of Dr. Mariotto has received research support from FISM. |
| Lakshman N. Arcot Jayagopal, MD | Dr. Arcot Jayagopal has nothing to disclose. |
| Alessandro Dinoto, MD | The institution of Dr. Dinoto has received research support from Encephalitis International . The institution of Dr. Dinoto has received research support from Autoimmune Encephalitis Alliance. |
| Ayush Gupta, MD | Dr. Gupta has nothing to disclose. |
| Elias T. Spiliotis, PhD | The institution of Dr. Spiliotis has received research support from NIH. |
| Anastasia Zekeridou, MD, PhD, FAAN | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Michael Gilligan, MBBS | Dr. Gilligan has nothing to disclose. |
| John R. Mills, MD, PhD | The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care. |
| Sulafa G. Saffarini, MD | Dr. Saffarini has nothing to disclose. |
| Madeleine Scharf, PhD | Dr. Scharf has received personal compensation for serving as an employee of Euroimmun AG. |